BCMA-Targeted Therapies in Multiple Myeloma

Review of BCMA-targeted therapies including BiTE, CAR T cells and antibody-drug conjugates in myeloma.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive